Related Experiment Video

Updated: Jul 16, 2026

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Scrub typhus vaccines: past history and recent developments

Suchismita Chattopadhyay1, Allen L Richards

  • 1Rickettsial Diseases Research Program, Naval Medical Research Center, Silver Spring, Maryland 20910, USA. ChattopadhyayS@nmrc.navy.mil.

Human Vaccines
|March 22, 2007
PubMed

Insights

Scrub typhus, a bacterial infection, requires a vaccine due to increasing outbreaks and antibiotic resistance. This review explores past and future vaccine development efforts for this potentially fatal disease.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Vaccinology

Background:

  • Scrub typhus is an acute, febrile, and potentially fatal disease caused by Orientia tsutsugamushi.
  • Prevalent in the Asia-Pacific region, it is typically managed with antibiotics and vector control.
  • Emerging antibiotic resistance and increased outbreaks highlight the need for alternative prevention strategies.

Purpose of the Study:

  • To review historical and current vaccine development for scrub typhus.
  • To analyze the successes and failures of past prophylactic preparations.
  • To outline future directions for scrub typhus vaccine research.

Main Methods:

  • Literature review of early and recent vaccine development attempts.
  • Analysis of published data on vaccine efficacy and challenges.
  • Synthesis of information on current research trends and future prospects.

Main Results:

  • Multiple vaccine development attempts have been made, with varying degrees of success.
  • Challenges include the complexity of Orientia tsutsugamushi and the need for broad-spectrum protection.
  • Recent advancements show promise, but a widely effective vaccine is yet to be realized.

Conclusions:

  • A prophylactic vaccine remains a critical unmet need for controlling scrub typhus.
  • Overcoming immunological hurdles and ensuring vaccine stability are key challenges.
  • Continued research into novel vaccine platforms and antigen discovery is essential for future success.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Related Concept Videos

Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccinations01:51

Vaccinations

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...